AzTrials
AzTrials

Induction of Labor Affected Fetus / NewbornNCT03086967

Cervical Ripening With a Double-lumen Balloon Catheter for Six Versus Twelve Hours

A study testing Double-lumen balloon catheter in people with Induction of Labor Affected Fetus / Newborn, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Foley catheter is a safe, effective method for cervical ripening. Limited data exists to indicate ideal time of placement for optimal cervical ripening prior to induction. The proposed study is a randomized control trial to determine if shortening placement from 12 to 6 hours of foley catheter can decrease time… Read more about this study

Who is it for?
Ages 16 to 45 years, women only
What is being tested?
Double-lumen balloon catheter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
204 participants
Where
1 siteUnited States
Study dates
Jun 2013to Feb 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 45 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Intrauterine pregnancy at 37 weeks gestational age or greater as determined by best obstetrical dating criteria
  • Singleton gestation
  • Vertex presentation
  • Clinically adequate pelvis
  • Bishop Score less than or equal to 6
  • 16 years and older
  • North Carolina state law provides for the emancipation of minors, Chapter 7B-Article 35.

Who cannot join

  • Any maternal or fetal contraindication to vaginal delivery
  • Known uterine anomaly
  • Multifetal gestation
  • Estimated fetal weight of 4500 gm or greater
  • Ruptured membranes

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Carolinas Medical Center

    Charlotte, North Carolina, 28232

Other trials in United States

About this study

The Foley catheter is a safe, effective method for cervical ripening. Limited data exists to indicate ideal time of placement for optimal cervical ripening prior to induction. The proposed study is a randomized control trial to determine if shortening placement from 12 to 6 hours of foley catheter can decrease time from start of induction to delivery. The prediction is that shortening foley bulb placement will result in shorter induction times, increased patient satisfaction and decreased length of stay on labor and delivery with secondary decreased medical costs.

Read the detailed description

Objective: To determine whether a double-lumen balloon catheter requires twelve hours in the cervical canal to achieve its maximal cervical dilation. It is the hypothesis that the maximum cervical dilation and benefits of a double lumen foley catheter are achieved within the initial six hours after placement.

Study Design:

Overview: All eligible patients with a singleton pregnancy at 37 weeks gestational age or greater who are presenting for a clinically/ medically indicated induction with an unfavorable cervical exam will be invited to participate. As per the American College of Obstetricians and Gynecologists (ACOG) guidelines, all inductions performed prior to 39 weeks are medically indicated. Medical indications for induction prior to 39 weeks include but are not limited to preeclampsia, oligohydramnios and growth restriction. Upon admission to Labor and Delivery, women will be assessed for eligibility by an obstetric physician. A digital cervical examination will be performed and a Bishop score assigned. Patients with a Bishop score ≤ 6 are thought to benefit from a cervical ripening agent and the participants will be randomized based on parity at this point.

Type of Study: This study will be a prospective, randomized clinical control trial with human subjects.

Materials and Methods:

A qualified obstetric provider will provide eligible women with details of the study, including study objectives and methods. Consent will be obtained and witnessed from patients who elect to participate. Enrollment and randomization in the study will then occur. Patients will be randomized to the two groups using computer generated random numbers. The randomization will be stratified based on parity (i.e., women who have had any prior vaginal delivery above 20 weeks gestation v. women who have not). A foley bulb will then be placed by a qualified obstetric provider. Foley bulb will be inserted with or without speculum technique and with or without use of a stylet. In accordance with the standard of care, sterile saline will be placed in the intrauterine and vaginal balloon as tolerated by the patient for no more than a maximum of 80 cc in each balloon. The use of concomitant low dose pitocin with the foley bulb will be at the discretion of the admitting obstetric team. If the patient's foley bulb does not spontaneously expel within the maximum allotted time, they will be manually removed at six or twelve hours. At the time of manual removal or expulsion of the foley balloon, the patient's cervix will be checked by an experienced obstetric provider. As per usual protocol, additional cervical ripening and labor induction will proceed per managing obstetric team.

Independent Variables:

Data collection will include the independent variables of maternal age, parity, BMI, race (Caucasian, African American, Hispanic, Asian, other), Bishop Score, use of magnesium and epidural use. Data collection of independent fetal variables will include gestational age and estimated fetal weight.

Outcome Variables:

The primary outcome will be time from foley bulb placement to time of delivery. Secondary outcomes will include time from foley bulb placement to extrusion and rate of cesarean section. Additional comparison variables include: neonatal weight, APGAR scores and intrapartum and postpartum infection rates.

Being tested
Double-lumen balloon catheter
Keywords
cervical ripening, double lumen catheter

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Double-lumen balloon catheterDevice

    Also called foley bulb

    introduction of catheter into cervix for ripening prior to induction of labor following standard of care practices

Study groups in NCT03086967
Study groupRoleWhat they receive
Six HourActive comparatorPlacement of foley catheter and extrusion after 6 hours followed by induction.
Receives: Device: Double-lumen balloon catheter
Twelve HourActive comparatorPlacement of foley catheter and extrusion after 12 hours followed by induction.
Receives: Device: Double-lumen balloon catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time From Foley Bulb Placement to Time of Delivery.

    Time in hours to delivery following use of foley catheter

    Measured: Change in time to delivery following bulb insertion for 6 hours up to 72 hours

  2. Time to Delivery of Trial of Labor After Cesarean Section

    Measured: Time (hours) to delivery

  3. 1 Minute Apgar Score of Trial of Labor After Cesarean Section

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

    Measured: 1 minute Apgar score following birth

Secondary outcomes (8)
  1. Time From Foley Bulb Placement to Extrusion

    Time in hours from foley bulb placement to extrusion

    Measured: Hour 6, Hour 12

  2. Mode of Delivery--Number of Participants Having Cesarean Delivery

    Measured: Hour Six, Hour 12

  3. Bacterial Infection (Chorioamnionitis)

    Measured: Hour Six, Hour 12

  4. Endometritis

    Measured: Hour 6, Hour 12

  5. 1 Minute Apgar Score

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

    Measured: 1 minute Apgar score following birth

  6. 5 Minute Apgar Score

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

    Measured: 5 minute Apgar score following birth

  7. Time to Foley Bulb Extrusion of Trial of Labor After Cesarean Section

    Measured: Time to foley bulb extrusion

  8. 5 Minute Apgar Score of Trial of Labor After Cesarean Section

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health.

    Measured: 5 Minute Apgar Score following birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2017
  2. Study startJun 2013
  3. Primary completionSep 2015
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
204 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03086967
Sponsor's protocol ID
06-13-03B
Status last verified
Mar 2017
First submitted
21 Feb 2017
Last updated
30 Nov 2022
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Double-lumen balloon catheter in people with Induction of Labor Affected Fetus / Newborn, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 30 Nov 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time From Foley Bulb Placement to Time of Delivery. (time frame: Change in time to delivery following bulb insertion for 6 hours up to 72 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in